[Long-term follow up after antithyroid drug treatment in Graves' disease]

Wille, T; Müller, B; Noth, D; Bürgi, U; Diem, P (2006). [Long-term follow up after antithyroid drug treatment in Graves' disease]. Praxis - schweizerische Rundschau für Medizin, 95(29-30), pp. 1121-7. Bern: Huber

Full text not available from this repository.

In Europe antithyroid drug (ATD) therapy is the preferred initial treatment for patients with a first episode of Graves' disease. Results of long-term recurrence rates following ATD therapy are conflicting. The main goal was to assess long-term recurrence rate after ATD treatment. Secondarily we tried to verify chemical and clinical findings (thyrotropin receptor antibodies (TRAb), duration of primary treatment, age and goitre size) as predictive factors.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Bürgi, Ulrich, Diem, Peter

ISSN:

1661-8157

ISBN:

16916174

Publisher:

Huber

Language:

German

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:46

Last Modified:

05 Dec 2022 14:14

PubMed ID:

16916174

URI:

https://boris.unibe.ch/id/eprint/19070 (FactScience: 1438)

Actions (login required)

Edit item Edit item
Provide Feedback